{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,8,31]],"date-time":"2026-08-31T13:13:35Z","timestamp":1788182015207,"version":"build-2803163510"},"reference-count":30,"publisher":"Elsevier BV","issue":"6","license":[{"start":{"date-parts":[[2026,6,1]],"date-time":"2026-06-01T00:00:00Z","timestamp":1780272000000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/tdm\/userlicense\/1.0\/"},{"start":{"date-parts":[[2026,6,1]],"date-time":"2026-06-01T00:00:00Z","timestamp":1780272000000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/legal\/tdmrep-license"},{"start":{"date-parts":[[2026,2,5]],"date-time":"2026-02-05T00:00:00Z","timestamp":1770249600000},"content-version":"vor","delay-in-days":0,"URL":"http:\/\/creativecommons.org\/licenses\/by\/4.0\/"}],"funder":[{"DOI":"10.13039\/100005189","name":"Leukemia and Lymphoma Society","doi-asserted-by":"publisher","award":["6676-24"],"award-info":[{"award-number":["6676-24"]}],"id":[{"id":"10.13039\/100005189","id-type":"DOI","asserted-by":"publisher"}]},{"DOI":"10.13039\/501100013362","name":"Stiftung Krebsforschung Schweiz","doi-asserted-by":"publisher","award":["KFS-4542-08-2018-R"],"award-info":[{"award-number":["KFS-4542-08-2018-R"]}],"id":[{"id":"10.13039\/501100013362","id-type":"DOI","asserted-by":"publisher"}]}],"content-domain":{"domain":["cell.com","elsevier.com","sciencedirect.com"],"crossmark-restriction":true},"short-container-title":["Molecular Therapy"],"published-print":{"date-parts":[[2026,6]]},"DOI":"10.1016\/j.ymthe.2026.02.004","type":"journal-article","created":{"date-parts":[[2026,2,6]],"date-time":"2026-02-06T17:12:34Z","timestamp":1770397954000},"page":"3405-3416","update-policy":"https:\/\/doi.org\/10.1016\/elsevier_cm_policy","source":"Crossref","is-referenced-by-count":0,"title":["CAR-modified marrow infiltrating lymphocytes efficiently target malignant plasma cells with very low antigen density"],"prefix":"10.1016","volume":"34","author":[{"given":"Nicolas","family":"Camviel","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Davide","family":"Gambarotto","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Violaine","family":"Andre","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Raphael","family":"Stadelmann","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Christian","family":"Sieben","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Raphael","family":"Gottardo","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Suliana","family":"Manley","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0001-6440-9970","authenticated-orcid":false,"given":"Caroline","family":"Arber","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"78","reference":[{"key":"10.1016\/j.ymthe.2026.02.004_bib1","doi-asserted-by":"crossref","first-page":"705","DOI":"10.1056\/NEJMoa2024850","article-title":"Idecabtagene Vicleucel in Relapsed and Refractory Multiple Myeloma","volume":"384","author":"Munshi","year":"2021","journal-title":"N. Engl. J. Med."},{"key":"10.1016\/j.ymthe.2026.02.004_bib2","doi-asserted-by":"crossref","first-page":"314","DOI":"10.1016\/S0140-6736(21)00933-8","article-title":"Ciltacabtagene autoleucel, a B-cell maturation antigen-directed chimeric antigen receptor T-cell therapy in patients with relapsed or refractory multiple myeloma (CARTITUDE-1): a phase 1b\/2 open-label study","volume":"398","author":"Berdeja","year":"2021","journal-title":"Lancet"},{"key":"10.1016\/j.ymthe.2026.02.004_bib3","doi-asserted-by":"crossref","first-page":"206","DOI":"10.1038\/s41408-024-01191-8","article-title":"CAR-T cell therapy in Multiple Myeloma: current status and future challenges","volume":"14","author":"Swan","year":"2024","journal-title":"Blood Cancer J."},{"key":"10.1016\/j.ymthe.2026.02.004_bib4","doi-asserted-by":"crossref","first-page":"746","DOI":"10.1182\/blood-2017-05-781351","article-title":"An APRIL-based chimeric antigen receptor for dual targeting of BCMA and TACI in multiple myeloma","volume":"131","author":"Lee","year":"2018","journal-title":"Blood"},{"key":"10.1016\/j.ymthe.2026.02.004_bib5","doi-asserted-by":"crossref","first-page":"3248","DOI":"10.1182\/bloodadvances.2019000703","article-title":"Rational design of a trimeric APRIL-based CAR-binding domain enables efficient targeting of multiple myeloma","volume":"3","author":"Schmidts","year":"2019","journal-title":"Blood Adv."},{"key":"10.1016\/j.ymthe.2026.02.004_bib6","doi-asserted-by":"crossref","DOI":"10.1136\/jitc-2022-005091","article-title":"Both APRIL and antibody-fragment-based CAR T cells for myeloma induce BCMA downmodulation by trogocytosis and internalization","volume":"10","author":"Camviel","year":"2022","journal-title":"J. Immunother. Cancer"},{"key":"10.1016\/j.ymthe.2026.02.004_bib7","doi-asserted-by":"crossref","first-page":"7509","DOI":"10.1038\/s41467-023-43416-7","article-title":"Anti-TACI single and dual-targeting CAR T cells overcome BCMA antigen loss in multiple myeloma","volume":"14","author":"Larson","year":"2023","journal-title":"Nat. Commun."},{"key":"10.1016\/j.ymthe.2026.02.004_bib8","doi-asserted-by":"crossref","first-page":"217","DOI":"10.1038\/s41467-021-27853-w","article-title":"A BAFF ligand-based CAR-T cell targeting three receptors and multiple B cell cancers","volume":"13","author":"Wong","year":"2022","journal-title":"Nat. Commun."},{"key":"10.1016\/j.ymthe.2026.02.004_bib9","doi-asserted-by":"crossref","first-page":"9751","DOI":"10.1038\/s41467-024-54150-z","article-title":"Split-design approach enhances the therapeutic efficacy of ligand-based CAR-T cells against multiple B-cell malignancies","volume":"15","author":"Li","year":"2024","journal-title":"Nat. Commun."},{"key":"10.1016\/j.ymthe.2026.02.004_bib10","doi-asserted-by":"crossref","DOI":"10.1136\/jitc-2023-006699","article-title":"Limited efficacy of APRIL CAR in patients with multiple myeloma indicate challenges in the use of natural ligands for CAR T-cell therapy","volume":"11","author":"Lee","year":"2023","journal-title":"J. Immunother. Cancer"},{"key":"10.1016\/j.ymthe.2026.02.004_bib11","doi-asserted-by":"crossref","DOI":"10.1016\/j.heliyon.2024.e27892","article-title":"Exploring cellular immunotherapy platforms in multiple myeloma","volume":"10","author":"Vo","year":"2024","journal-title":"Heliyon"},{"key":"10.1016\/j.ymthe.2026.02.004_bib12","doi-asserted-by":"crossref","first-page":"2026","DOI":"10.1158\/0008-5472.CAN-04-3337","article-title":"Activated marrow-infiltrating lymphocytes effectively target plasma cells and their clonogenic precursors","volume":"65","author":"Noonan","year":"2005","journal-title":"Cancer Res."},{"key":"10.1016\/j.ymthe.2026.02.004_bib13","doi-asserted-by":"crossref","first-page":"450","DOI":"10.1158\/1078-0432.CCR-19-2309","article-title":"Mutation-derived Neoantigen-specific T-cell Responses in Multiple Myeloma","volume":"26","author":"Perumal","year":"2020","journal-title":"Clin. Cancer Res."},{"key":"10.1016\/j.ymthe.2026.02.004_bib14","doi-asserted-by":"crossref","DOI":"10.1016\/j.tranon.2025.102475","article-title":"Expanded and activated marrow-infiltrating lymphocytes exhibit potent antimyeloma activity against autologous multiple myeloma cells","volume":"60","author":"Ahn","year":"2025","journal-title":"Transl. Oncol."},{"key":"10.1016\/j.ymthe.2026.02.004_bib15","doi-asserted-by":"crossref","DOI":"10.1126\/scitranslmed.aaa7014","article-title":"Adoptive transfer of activated marrow-infiltrating lymphocytes induces measurable antitumor immunity in the bone marrow in multiple myeloma","volume":"7","author":"Noonan","year":"2015","journal-title":"Sci. Transl. Med."},{"key":"10.1016\/j.ymthe.2026.02.004_bib16","doi-asserted-by":"crossref","first-page":"26","DOI":"10.1186\/s12979-020-00195-9","article-title":"Genetic and environmental determinants of human TCR repertoire diversity","volume":"17","author":"Krishna","year":"2020","journal-title":"Immun. Ageing."},{"key":"10.1016\/j.ymthe.2026.02.004_bib17","doi-asserted-by":"crossref","first-page":"3137","DOI":"10.1038\/s41467-019-10948-w","article-title":"Super-resolution microscopy reveals ultra-low CD19 expression on myeloma cells that triggers elimination by CD19 CAR-T","volume":"10","author":"Nerreter","year":"2019","journal-title":"Nat. Commun."},{"key":"10.1016\/j.ymthe.2026.02.004_bib18","doi-asserted-by":"crossref","first-page":"610","DOI":"10.1038\/nbt.3187","article-title":"COMPASS identifies T-cell subsets correlated with clinical outcomes","volume":"33","author":"Lin","year":"2015","journal-title":"Nat. Biotechnol."},{"key":"10.1016\/j.ymthe.2026.02.004_bib19","doi-asserted-by":"crossref","first-page":"689","DOI":"10.1182\/blood-2003-06-2043","article-title":"Expression of BCMA, TACI, and BAFF-R in multiple myeloma: a mechanism for growth and survival","volume":"103","author":"Novak","year":"2004","journal-title":"Blood"},{"key":"10.1016\/j.ymthe.2026.02.004_bib20","doi-asserted-by":"crossref","first-page":"7276","DOI":"10.4049\/jimmunol.179.11.7276","article-title":"Regulated expression of BAFF-binding receptors during human B cell differentiation","volume":"179","author":"Darce","year":"2007","journal-title":"J. Immunol."},{"key":"10.1016\/j.ymthe.2026.02.004_bib21","doi-asserted-by":"crossref","first-page":"6675","DOI":"10.1158\/0008-5472.CAN-06-0190","article-title":"Role of B-cell-activating factor in adhesion and growth of human multiple myeloma cells in the bone marrow microenvironment","volume":"66","author":"Tai","year":"2006","journal-title":"Cancer Res."},{"key":"10.1016\/j.ymthe.2026.02.004_bib22","doi-asserted-by":"crossref","first-page":"1676","DOI":"10.1007\/s10147-024-02611-2","article-title":"Current status of BAFF targeting immunotherapy in B-cell neoplasm","volume":"29","author":"Tagami","year":"2024","journal-title":"Int. J. Clin. Oncol."},{"key":"10.1016\/j.ymthe.2026.02.004_bib23","doi-asserted-by":"crossref","first-page":"939","DOI":"10.1111\/bjh.14899","article-title":"Engineered T cells towards TNFRSF13C (BAFFR): a novel strategy to efficiently target B-cell acute lymphoblastic leukaemia","volume":"182","author":"Turazzi","year":"2018","journal-title":"Br. J. Haematol."},{"key":"10.1016\/j.ymthe.2026.02.004_bib24","doi-asserted-by":"crossref","DOI":"10.1126\/scitranslmed.aaw9414","article-title":"CAR T cells targeting BAFF-R can overcome CD19 antigen loss in B cell malignancies","volume":"11","author":"Qin","year":"2019","journal-title":"Sci. Transl. Med."},{"key":"10.1016\/j.ymthe.2026.02.004_bib25","doi-asserted-by":"crossref","first-page":"1407","DOI":"10.1158\/2326-6066.CIR-22-0434","article-title":"Immune Phenotypes and Target Antigens of Clonally Expanded Bone Marrow T Cells in Treatment-Naive Multiple Myeloma","volume":"10","author":"Welters","year":"2022","journal-title":"Cancer Immunol. Res."},{"key":"10.1016\/j.ymthe.2026.02.004_bib26","first-page":"132","article-title":"Using CombiCells, a platform for titration and combinatorial display of cell surface ligands, to study T-cell antigen sensitivity modulation by accessory receptors","volume":"43","author":"Patel","year":"2024","journal-title":"EMBO J."},{"key":"10.1016\/j.ymthe.2026.02.004_bib27","doi-asserted-by":"crossref","DOI":"10.1371\/journal.pone.0069004","article-title":"Resolution doubling in 3D-STORM imaging through improved buffers","volume":"8","author":"Olivier","year":"2013","journal-title":"PLoS One"},{"key":"10.1016\/j.ymthe.2026.02.004_bib28","doi-asserted-by":"crossref","first-page":"705","DOI":"10.1038\/nphoton.2016.200","article-title":"Super-resolution imaging of multiple cells by optimised flat-field epi-illumination","volume":"10","author":"Douglass","year":"2016","journal-title":"Nat. Photon."},{"key":"10.1016\/j.ymthe.2026.02.004_bib29","doi-asserted-by":"crossref","first-page":"653","DOI":"10.1038\/nmeth.2488","article-title":"Video-rate nanoscopy using sCMOS camera-specific single-molecule localization algorithms","volume":"10","author":"Huang","year":"2013","journal-title":"Nat. Methods"},{"key":"10.1016\/j.ymthe.2026.02.004_bib30","article-title":"TCR sequencing and cloning methods for repertoire analysis and isolation of tumor-reactive TCRs","volume":"3","author":"Genolet","year":"2023","journal-title":"Cell Rep. Methods"}],"container-title":["Molecular Therapy"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S1525001626000900?httpAccept=text\/xml","content-type":"text\/xml","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S1525001626000900?httpAccept=text\/plain","content-type":"text\/plain","content-version":"vor","intended-application":"text-mining"}],"deposited":{"date-parts":[[2026,8,31]],"date-time":"2026-08-31T12:15:04Z","timestamp":1788178504000},"score":1,"resource":{"primary":{"URL":"https:\/\/linkinghub.elsevier.com\/retrieve\/pii\/S1525001626000900"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2026,6]]},"references-count":30,"journal-issue":{"issue":"6","published-print":{"date-parts":[[2026,6]]}},"alternative-id":["S1525001626000900"],"URL":"https:\/\/doi.org\/10.1016\/j.ymthe.2026.02.004","relation":{},"ISSN":["1525-0016"],"issn-type":[{"value":"1525-0016","type":"print"}],"subject":[],"published":{"date-parts":[[2026,6]]},"assertion":[{"value":"Elsevier","name":"publisher","label":"This article is maintained by"},{"value":"CAR-modified marrow infiltrating lymphocytes efficiently target malignant plasma cells with very low antigen density","name":"articletitle","label":"Article Title"},{"value":"Molecular Therapy","name":"journaltitle","label":"Journal Title"},{"value":"https:\/\/doi.org\/10.1016\/j.ymthe.2026.02.004","name":"articlelink","label":"CrossRef DOI link to publisher maintained version"},{"value":"article","name":"content_type","label":"Content Type"},{"value":"\u00a9 2026 The Author(s). Published by Elsevier Inc. on behalf of The American Society of Gene and Cell Therapy.","name":"copyright","label":"Copyright"}]}}